Search research articles
Contact Us
Filters
Showing results (11-20 of 49) with videos related to
Page
of 5
Sort By:
European Journal of Pharmacology
|
July 10, 2017
Inhibition of the kynurenine pathway protects against reactive microglial-associated reductions in the complexity of primary cortical neurons
Katherine O'Farrell, Eimear Fagan, Thomas J Connor, et al.
Journal of Neuroimmunology
|
November 2, 2010
Complementary anti-inflammatory actions of the β₂-adrenoceptor agonist clenbuterol and the glucocorticoid dexamethasone in rat brain
Katie J Ryan, Eadaoin W Griffin, Thomas J Connor
Neuroimmunomodulation
|
September 17, 2005
The effects of vagus nerve stimulation on pro- and anti-inflammatory cytokines in humans: a preliminary report
Ciaran Corcoran, Thomas J Connor, Veronica O'Keane, et al.
Journal of Neuroimmunology
|
January 18, 2005
Acute stress suppresses pro-inflammatory cytokines TNF-alpha and IL-1 beta independent of a catecholamine-driven increase in IL-10 production
Thomas J Connor, Charlene Brewer, John P Kelly, et al.
Brain, Behavior, and Immunity
|
January 23, 2009
Psychological stress increases expression of IL-10 and its homolog IL-19 via beta-adrenoceptor activation: reversal by the anxiolytic chlordiazepoxide
Niamh M Curtin, Kingston H G Mills, Thomas J Connor
Neuroscience Letters
|
July 1, 2008
Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?
Thomas J Connor, Neasa Starr, Joan B O'Sullivan, et al.
Neuroimmunomodulation
|
August 9, 2003
Inhibition of constitutive nitric oxide production increases the severity of lipopolysaccharide-induced sickness behaviour: a role for TNF-alpha
Thomas J Connor, Joan O'Sullivan, Yvonne Nolan, et al.
The European Journal of Neuroscience
|
August 20, 2003
Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine
Andrew Harkin, Eamonn Shanahan, John P Kelly, et al.
Journal of Neuroimmunology
|
November 11, 2019
Dexamethasone attenuates inflammatory-mediated suppression of β<sub>2</sub>-adrenoceptor expression in rat primary mixed glia
Karen M Ryan, Noreen T Boyle, Andrew Harkin, et al.
Neuropharmacology
|
February 25, 2012
Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease
Louise M Collins, André Toulouse, Thomas J Connor, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 49) with videos related to
Sort By:
Page
of 5
European Journal of Pharmacology
|
July 10, 2017
Inhibition of the kynurenine pathway protects against reactive microglial-associated reductions in the complexity of primary cortical neurons
Katherine O'Farrell, Eimear Fagan, Thomas J Connor, et al.
Journal of Neuroimmunology
|
November 2, 2010
Complementary anti-inflammatory actions of the β₂-adrenoceptor agonist clenbuterol and the glucocorticoid dexamethasone in rat brain
Katie J Ryan, Eadaoin W Griffin, Thomas J Connor
Neuroimmunomodulation
|
September 17, 2005
The effects of vagus nerve stimulation on pro- and anti-inflammatory cytokines in humans: a preliminary report
Ciaran Corcoran, Thomas J Connor, Veronica O'Keane, et al.
Journal of Neuroimmunology
|
January 18, 2005
Acute stress suppresses pro-inflammatory cytokines TNF-alpha and IL-1 beta independent of a catecholamine-driven increase in IL-10 production
Thomas J Connor, Charlene Brewer, John P Kelly, et al.
Brain, Behavior, and Immunity
|
January 23, 2009
Psychological stress increases expression of IL-10 and its homolog IL-19 via beta-adrenoceptor activation: reversal by the anxiolytic chlordiazepoxide
Niamh M Curtin, Kingston H G Mills, Thomas J Connor
Neuroscience Letters
|
July 1, 2008
Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?
Thomas J Connor, Neasa Starr, Joan B O'Sullivan, et al.
Neuroimmunomodulation
|
August 9, 2003
Inhibition of constitutive nitric oxide production increases the severity of lipopolysaccharide-induced sickness behaviour: a role for TNF-alpha
Thomas J Connor, Joan O'Sullivan, Yvonne Nolan, et al.
The European Journal of Neuroscience
|
August 20, 2003
Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine
Andrew Harkin, Eamonn Shanahan, John P Kelly, et al.
Journal of Neuroimmunology
|
November 11, 2019
Dexamethasone attenuates inflammatory-mediated suppression of β<sub>2</sub>-adrenoceptor expression in rat primary mixed glia
Karen M Ryan, Noreen T Boyle, Andrew Harkin, et al.
Neuropharmacology
|
February 25, 2012
Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease
Louise M Collins, André Toulouse, Thomas J Connor, et al.
Page
of 5